311 related articles for article (PubMed ID: 10496959)
1. Inhibition of aryl hydrocarbon-induced cytochrome P-450 1A1 enzyme activity and CYP1A1 expression by resveratrol.
Ciolino HP; Yeh GC
Mol Pharmacol; 1999 Oct; 56(4):760-7. PubMed ID: 10496959
[TBL] [Abstract][Full Text] [Related]
2. Diosmin and diosmetin are agonists of the aryl hydrocarbon receptor that differentially affect cytochrome P450 1A1 activity.
Ciolino HP; Wang TT; Yeh GC
Cancer Res; 1998 Jul; 58(13):2754-60. PubMed ID: 9661887
[TBL] [Abstract][Full Text] [Related]
3. Resveratrol inhibits transcription of CYP1A1 in vitro by preventing activation of the aryl hydrocarbon receptor.
Ciolino HP; Daschner PJ; Yeh GC
Cancer Res; 1998 Dec; 58(24):5707-12. PubMed ID: 9865727
[TBL] [Abstract][Full Text] [Related]
4. A novel synthetic analogue of a constituent of Isodon excisus inhibits transcription of CYP1A1, -1A2 and -1B1 by preventing activation of the aryl hydrocarbon receptor.
Sienkiewicz P; Ciolino HP; Leslie BJ; Hergenrother PJ; Singletary K; Yeh GC
Carcinogenesis; 2007 May; 28(5):1052-7. PubMed ID: 17183067
[TBL] [Abstract][Full Text] [Related]
5. Abundance of aryl hydrocarbon receptor potentiates benzo[a]pyrene-induced apoptosis in Hepa1c1c7 cells via CYP1A1 activation.
Chung JY; Kim JY; Kim WR; Lee SG; Kim YJ; Park JE; Hong YP; Chun YJ; Park YC; Oh S; Yoo KS; Yoo YH; Kim JM
Toxicology; 2007 Jun; 235(1-2):62-72. PubMed ID: 17433523
[TBL] [Abstract][Full Text] [Related]
6. Benzo[g,h,i]perylene synergistically transactivates benzo[a]pyrene-induced CYP1A1 gene expression by aryl hydrocarbon receptor pathway.
Cherng SH; Lin P; Yang JL; Hsu SL; Lee H
Toxicol Appl Pharmacol; 2001 Jan; 170(1):63-8. PubMed ID: 11141357
[TBL] [Abstract][Full Text] [Related]
7. Dibenzoylmethane modulates aryl hydrocarbon receptor function and expression of cytochromes P50 1A1, 1A2, and 1B1.
MacDonald CJ; Ciolino HP; Yeh GC
Cancer Res; 2001 May; 61(10):3919-24. PubMed ID: 11358806
[TBL] [Abstract][Full Text] [Related]
8. Curcumin activates the aryl hydrocarbon receptor yet significantly inhibits (-)-benzo(a)pyrene-7R-trans-7,8-dihydrodiol bioactivation in oral squamous cell carcinoma cells and oral mucosa.
Rinaldi AL; Morse MA; Fields HW; Rothas DA; Pei P; Rodrigo KA; Renner RJ; Mallery SR
Cancer Res; 2002 Oct; 62(19):5451-6. PubMed ID: 12359752
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol, a natural aryl hydrocarbon receptor antagonist, protects lung from DNA damage and apoptosis caused by benzo[a]pyrene.
Revel A; Raanani H; Younglai E; Xu J; Rogers I; Han R; Savouret JF; Casper RF
J Appl Toxicol; 2003; 23(4):255-61. PubMed ID: 12884409
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
11. Effect of curcumin on the aryl hydrocarbon receptor and cytochrome P450 1A1 in MCF-7 human breast carcinoma cells.
Ciolino HP; Daschner PJ; Wang TT; Yeh GC
Biochem Pharmacol; 1998 Jul; 56(2):197-206. PubMed ID: 9698073
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol inhibits dioxin-induced expression of human CYP1A1 and CYP1B1 by inhibiting recruitment of the aryl hydrocarbon receptor complex and RNA polymerase II to the regulatory regions of the corresponding genes.
Beedanagari SR; Bebenek I; Bui P; Hankinson O
Toxicol Sci; 2009 Jul; 110(1):61-7. PubMed ID: 19376845
[TBL] [Abstract][Full Text] [Related]
13. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
14. CYP1A1 and CYP1B1 expressions in medulloblastoma cells are AhR-independent and have no direct link with resveratrol-induced differentiation and apoptosis.
Wu ML; Li H; Wu DC; Wang XW; Chen XY; Kong QY; Ma JX; Gao Y; Liu J
Neurosci Lett; 2005 Aug 12-19; 384(1-2):33-7. PubMed ID: 15893423
[TBL] [Abstract][Full Text] [Related]
15. Sulindac regulates the aryl hydrocarbon receptor-mediated expression of Phase 1 metabolic enzymes in vivo and in vitro.
Ciolino HP; MacDonald CJ; Memon OS; Bass SE; Yeh GC
Carcinogenesis; 2006 Aug; 27(8):1586-92. PubMed ID: 16531450
[TBL] [Abstract][Full Text] [Related]
16. The flavonoid galangin is an inhibitor of CYP1A1 activity and an agonist/antagonist of the aryl hydrocarbon receptor.
Ciolino HP; Yeh GC
Br J Cancer; 1999 Mar; 79(9-10):1340-6. PubMed ID: 10188874
[TBL] [Abstract][Full Text] [Related]
17. Omeprazole alleviates benzo[a]pyrene cytotoxicity by inhibition of CYP1A1 activity in human and mouse hepatoma cells.
Shiizaki K; Ohsako S; Kawanishi M; Yagi T
Basic Clin Pharmacol Toxicol; 2008 Nov; 103(5):468-75. PubMed ID: 18793272
[TBL] [Abstract][Full Text] [Related]
18. Lung carcinogenesis: resveratrol modulates the expression of genes involved in the metabolism of PAH in human bronchial epithelial cells.
Mollerup S; Ovrebø S; Haugen A
Int J Cancer; 2001 Apr; 92(1):18-25. PubMed ID: 11279601
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of carcinogen-activating enzymes by 16alpha-fluoro-5-androsten-17-one.
Ciolino HP; MacDonald CJ; Yeh GC
Cancer Res; 2002 Jul; 62(13):3685-90. PubMed ID: 12097275
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D receptor activation enhances benzo[a]pyrene metabolism via CYP1A1 expression in macrophages.
Matsunawa M; Akagi D; Uno S; Endo-Umeda K; Yamada S; Ikeda K; Makishima M
Drug Metab Dispos; 2012 Nov; 40(11):2059-66. PubMed ID: 22837390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
